Cryo-Cell Income After Taxes 2010-2025 | CCEL

Cryo-Cell income after taxes from 2010 to 2025. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Cryo-Cell Annual Income After Taxes
(Millions of US $)
2024 $0
2023 $-10
2022 $3
2021 $2
2020 $4
2019 $2
2018 $-1
2017 $2
2016 $-1
2015 $8
2014 $1
2013 $0
2012 $-6
2011 $-2
2010 $3
2009 $1
Cryo-Cell Quarterly Income After Taxes
(Millions of US $)
2025-02-28 $0
2024-11-30 $-2
2024-08-31 $1
2024-05-31 $1
2024-02-29 $1
2023-11-30 $-11
2023-08-31 $1
2023-05-31 $0
2023-02-28 $1
2022-11-30 $1
2022-08-31 $0
2022-05-31 $1
2022-02-28 $1
2021-11-30 $-1
2021-08-31 $1
2021-05-31 $1
2021-02-28 $1
2020-11-30 $1
2020-08-31 $1
2020-05-31 $1
2020-02-29 $1
2019-11-30 $1
2019-08-31 $1
2019-05-31 $0
2019-02-28 $0
2018-11-30 $1
2018-08-31 $0
2018-05-31 $1
2018-02-28 $-3
2017-11-30 $1
2017-08-31 $1
2017-05-31 $0
2017-02-28 $0
2016-11-30 $1
2016-08-31 $-3
2016-05-31 $1
2016-02-29 $0
2015-11-30 $0
2015-08-31 $8
2015-05-31 $0
2015-02-28 $0
2014-11-30 $0
2014-08-31 $0
2014-05-31 $0
2014-02-28 $0
2013-11-30 $0
2013-08-31 $0
2013-05-31 $0
2013-02-28 $0
2012-11-30 $-1
2012-08-31 $-1
2012-05-31 $-3
2012-02-29 $-2
2011-11-30 $0
2011-08-31 $-2
2011-05-31 $0
2011-02-28 $0
2010-11-30 $0
2010-08-31 $2
2010-05-31 $0
2010-02-28 $0
2009-11-30 $0
2009-08-31 $0
2009-05-31 $1
2009-02-28 $1
Sector Industry Market Cap Revenue
Medical Medical Services $0.040B $0.032B
CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.350B 26.32
Elevance Health (ELV) United States $91.117B 11.76
CVS Health (CVS) United States $79.102B 9.83
Cencora (COR) United States $56.251B 19.57
DiDi Global (DIDIY) China $21.979B 33.36
Natera (NTRA) United States $20.836B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.822B 13.57
EUROFINS SCIENT (ERFSF) Luxembourg $12.604B 0.00
CochLear (CHEOY) Australia $11.282B 0.00
Revvity (RVTY) United States $10.993B 18.92
ICON (ICLR) Ireland $10.630B 9.88
Viatris (VTRS) United States $10.375B 3.56
Doximity (DOCS) United States $9.813B 45.70
Avantor (AVTR) United States $9.138B 13.28
Medpace Holdings (MEDP) United States $8.785B 23.33
HealthEquity (HQY) United States $8.497B 41.80
Sonic Healthcare (SKHHY) Australia $8.220B 0.00
Charles River Laboratories (CRL) United States $6.924B 13.57
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.257B 39.40
Bausch + Lomb (BLCO) Canada $4.156B 24.50
Sotera Health (SHC) United States $3.633B 20.65
Alignment Healthcare (ALHC) United States $3.122B 0.00
Surgery Partners (SGRY) United States $3.068B 39.90
Concentras Parent (CON) United States $2.912B 16.83
Organon (OGN) United States $2.350B 2.50
Ardent Health Partners (ARDT) United States $2.204B 9.40
GeneDx Holdings (WGS) United States $1.949B 75.07
Progyny (PGNY) United States $1.912B 42.08
Premier (PINC) United States $1.904B 14.45
PACS (PACS) United States $1.647B 0.00
GoodRx Holdings (GDRX) United States $1.414B 28.29
Teladoc Health (TDOC) United States $1.319B 0.00
Pediatrix Medical (MD) United States $1.283B 9.76
Establishment Labs Holdings (ESTA) $1.046B 0.00
Agilon Health (AGL) United States $1.014B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.977B 15.25
Nutex Health (NUTX) United States $0.972B 14.69
AMN Healthcare Services Inc (AMN) United States $0.869B 8.13
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.702B 4.73
InnovAge Holding (INNV) United States $0.566B 0.00
Enhabit (EHAB) United States $0.539B 44.33
Auna S.A (AUNA) Luxembourg $0.514B 13.63
Sonida Senior Living (SNDA) United States $0.494B 0.00
LifeMD (LFMD) United States $0.487B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.370B 0.00
SBC Medicals (SBC) United States $0.352B 0.00
Oncology Institute (TOI) United States $0.226B 0.00
Beauty Health (SKIN) United States $0.218B 0.00
Performant Healthcare (PHLT) United States $0.209B 0.00
DocGo (DCGO) United States $0.150B 24.50
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.084B 0.00
OncoCyte (OCX) United States $0.080B 0.00
KindlyMD (KDLY) United States $0.078B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
NeueHealth (NEUE) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Biodesix (BDSX) United States $0.044B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
Pheton Holdings (PTHL) China $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
ModivCare (MODV) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00